Elevated RAD51 expression also correlated with poor overall survival in two different datasets of EAC (GSE13898; cutoff: 6.237) and TCGA (cutoff: 363.63) as well as in colon (cutoff: 261) and breast cancer (cutoff: 6.31) (Figure 1B). Here, RAD51 is linked to breast cancer.